Barrow Brain Tumor Research Center

Phoenix, AZ, United States

Barrow Brain Tumor Research Center

Phoenix, AZ, United States

Time filter

Source Type

Kusne Y.,Barrow Brain Tumor Research Center | Sanai N.,Barrow Brain Tumor Research Center
Advances in Experimental Medicine and Biology | Year: 2015

Gliomas are primary cancers of the brain and the most lethal cancers known to man. In recent years the discovery of germinal regions in the postnatal brain containing neuronal stem and progenitor cell populations has led to the hypothesis that these cells may themselves serve as an origin of brain tumors. Stem cells that reside within the glioma tumor have been shown to display nonneoplastic stem-like characteristics, including expression of various stem cell markers, as well as capacity for self-renewal and multipotency. Furthermore, glioma tumors display marked similarities to the germinal regions of the brain. Investigations of human neural stem cells and their potential for malignancy may fi nally identify a cell-oforigin for human gliomas. This, in turn, may facilitate better therapeutic targeting leading to improved prognosis for glioma patients. © Springer International Publishing Switzerland 2015.


PubMed | Barrow Brain Tumor Research Center
Type: | Journal: Advances in experimental medicine and biology | Year: 2015

Gliomas are primary cancers of the brain and the most lethal cancers known to man. In recent years the discovery of germinal regions in the postnatal brain containing neuronal stem and progenitor cell populations has led to the hypothesis that these cells may themselves serve as an origin of brain tumors. Stem cells that reside within the glioma tumor have been shown to display nonneoplastic stem-like characteristics, including expression of various stem cell markers, as well as capacity for self-renewal and multipotency. Furthermore, glioma tumors display marked similarities to the germinal regions of the brain. Investigations of human neural stem cells and their potential for malignancy may finally identify a cell-of-origin for human gliomas. This, in turn, may facilitate better therapeutic targeting leading to improved prognosis for glioma patients.

Loading Barrow Brain Tumor Research Center collaborators
Loading Barrow Brain Tumor Research Center collaborators